481 related articles for article (PubMed ID: 23527669)
1. Assessment of extended-release opioid analgesics for the treatment of chronic pain.
Gudin JA
J Pain Palliat Care Pharmacother; 2013 Mar; 27(1):49-61. PubMed ID: 23527669
[TBL] [Abstract][Full Text] [Related]
2. Primary care considerations of the pharmacokinetics and clinical use of extended-release opioids in treating patients with chronic noncancer pain.
Nicholson B
Postgrad Med; 2013 Jan; 125(1):115-27. PubMed ID: 23391677
[TBL] [Abstract][Full Text] [Related]
3. Legal liability perspectives on abuse-deterrent opioids in the treatment of chronic pain.
Brushwood DB; Rich BA; Coleman JJ; Bolen J; Wong W
J Pain Palliat Care Pharmacother; 2010 Dec; 24(4):333-48. PubMed ID: 21133741
[TBL] [Abstract][Full Text] [Related]
4. Use of prescription opioids with abuse-deterrent technology to address opioid abuse.
Michna E; Kirson NY; Shei A; Birnbaum HG; Ben-Joseph R
Curr Med Res Opin; 2014 Aug; 30(8):1589-98. PubMed ID: 24738694
[TBL] [Abstract][Full Text] [Related]
5. The Clinical Applications of Extended-Release Abuse-Deterrent Opioids.
Vadivelu N; Schermer E; Kodumudi G; Berger JM
CNS Drugs; 2016 Jul; 30(7):637-46. PubMed ID: 27290716
[TBL] [Abstract][Full Text] [Related]
6. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part 2--guidance.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S67-116. PubMed ID: 22786449
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of an Extended-Release, Abuse-Deterrent, Microsphere-in-Capsule Analgesic for the Management of Patients with Chronic Pain With Dysphagia (CPD).
Fleming AB; Carlson DR; Varanasi RK; Grima M; Mayock SP; Saim S; Kopecky EA
Pain Pract; 2016 Mar; 16(3):334-44. PubMed ID: 25639548
[TBL] [Abstract][Full Text] [Related]
8. Opioids for chronic noncancer pain: still no evidence for superiority of sustained-release opioids.
Pedersen L; Fredheim O
Clin Pharmacol Ther; 2015 Feb; 97(2):114-5. PubMed ID: 25670511
[TBL] [Abstract][Full Text] [Related]
9. Routes of abuse of prescription opioid analgesics: a review and assessment of the potential impact of abuse-deterrent formulations.
Gasior M; Bond M; Malamut R
Postgrad Med; 2016 Jan; 128(1):85-96. PubMed ID: 26566680
[TBL] [Abstract][Full Text] [Related]
10. American Society of Interventional Pain Physicians (ASIPP) guidelines for responsible opioid prescribing in chronic non-cancer pain: Part I--evidence assessment.
Manchikanti L; Abdi S; Atluri S; Balog CC; Benyamin RM; Boswell MV; Brown KR; Bruel BM; Bryce DA; Burks PA; Burton AW; Calodney AK; Caraway DL; Cash KA; Christo PJ; Damron KS; Datta S; Deer TR; Diwan S; Eriator I; Falco FJ; Fellows B; Geffert S; Gharibo CG; Glaser SE; Grider JS; Hameed H; Hameed M; Hansen H; Harned ME; Hayek SM; Helm S; Hirsch JA; Janata JW; Kaye AD; Kaye AM; Kloth DS; Koyyalagunta D; Lee M; Malla Y; Manchikanti KN; McManus CD; Pampati V; Parr AT; Pasupuleti R; Patel VB; Sehgal N; Silverman SM; Singh V; Smith HS; Snook LT; Solanki DR; Tracy DH; Vallejo R; Wargo BW;
Pain Physician; 2012 Jul; 15(3 Suppl):S1-65. PubMed ID: 22786448
[TBL] [Abstract][Full Text] [Related]
11. Long-term efficacy, safety and tolerability of Remoxy for the management of chronic pain.
Pergolizzi JV; Zampogna G; Taylor R; Raffa RB
Expert Rev Neurother; 2015 Mar; 15(3):231-8. PubMed ID: 25683255
[TBL] [Abstract][Full Text] [Related]
12. Projecting the cost, utilization, and patient care impact of prescribing extended release non-abuse-deterrent opioids to chronic pain patients.
Yenikomshian MA; White AG; Carson ME; Garrison LP; Oderda GM; Biskupiak JE; Hlavacek PR; Roland CL
J Opioid Manag; 2017; 13(5):291-301. PubMed ID: 29199395
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the durability of pain relief throughout a 12 hour dosing interval of a novel, extended-release, abuse-deterrent formulation of oxycodone.
Nalamachu S; Kopecky EA; Taylor R; Vaughn B; O'Connor M
Curr Med Res Opin; 2016 Jul; 32(7):1311-7. PubMed ID: 27025986
[TBL] [Abstract][Full Text] [Related]
14. Risk Evaluation and Mitigation Strategies (REMS) for extended-release and long-acting opioid analgesics: considerations for palliative care practice.
Gudin J
J Pain Palliat Care Pharmacother; 2012 Jun; 26(2):136-43. PubMed ID: 22764852
[TBL] [Abstract][Full Text] [Related]
15. Update on abuse-resistant and abuse-deterrent approaches to opioid formulations.
Webster L
Pain Med; 2009 Jul; 10 Suppl 2():S124-33. PubMed ID: 19691683
[TBL] [Abstract][Full Text] [Related]
16. Mitigation of IV Abuse Through the Use of Abuse-Deterrent Opioid Formulations: An Overview of Current Technologies.
Rauck RL
Pain Pract; 2019 Apr; 19(4):443-454. PubMed ID: 30597739
[TBL] [Abstract][Full Text] [Related]
17. Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids.
Stanos S
Phys Sportsmed; 2012 Nov; 40(4):12-20. PubMed ID: 23306411
[TBL] [Abstract][Full Text] [Related]
18. Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids.
Woolf CJ; Hashmi M
Curr Opin Investig Drugs; 2004 Jan; 5(1):61-6. PubMed ID: 14983975
[TBL] [Abstract][Full Text] [Related]
19. Extended-release Tramadol (ULTRAM ER): a pharmacotherapeutic, pharmacokinetic, and pharmacodynamic focus on effectiveness and safety in patients with chronic/persistent pain.
Barkin RL
Am J Ther; 2008; 15(2):157-66. PubMed ID: 18356636
[TBL] [Abstract][Full Text] [Related]
20. Current and future development of extended-release, abuse-deterrent opioid formulations in the United States.
Webster LR; Markman J; Cone EJ; Niebler G
Postgrad Med; 2017 Jan; 129(1):102-110. PubMed ID: 27915497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
